Foam Sclerotherapy for Fibrovein now approved in Europe

Uncategorized
Written By Andrew Keese

STD Pharmaceutical has now obtained Marketing Authorization for Fibrovein Foam through the Ministries of Health of the United Kingdom, France, Spain, Portugal and the Czech Republic.  The specified approval was for Sodium Tetradecyl Sulphate (Fibrovein) concentrations of 3% and 1% with air:liquid ratios of 3:1 and 4:1.

Andrew Keese

Web designer, web developer and online marketing consultant. Co-owner of Silver Vine, a web design agency located in Melbourne, Australia.

https://silvervine.com.au
Previous

New Techniques of Varicose Vein Removal
Next

The Frequency of Varicose Veins in Men and Women